Anna Morena D’Alise

2.5k total citations
42 papers, 1.7k citations indexed

About

Anna Morena D’Alise is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Anna Morena D’Alise has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 19 papers in Oncology and 19 papers in Genetics. Recurrent topics in Anna Morena D’Alise's work include Immunotherapy and Immune Responses (16 papers), Virus-based gene therapy research (15 papers) and CAR-T cell therapy research (12 papers). Anna Morena D’Alise is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Virus-based gene therapy research (15 papers) and CAR-T cell therapy research (12 papers). Anna Morena D’Alise collaborates with scholars based in Italy, United States and Switzerland. Anna Morena D’Alise's co-authors include Stephen S. Taylor, Stefano Santaguida, Anthony Tighe, Christophe Benoıst, Diane Mathis, Elisa Scarselli, Alfredo Nicosia, Giovanni Amabile, Emanuele Sasso and Riccardo Cortese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Anna Morena D’Alise

39 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Morena D’Alise Italy 19 866 592 464 449 349 42 1.7k
Jacqueline K. Rainger United Kingdom 7 826 1.0× 771 1.3× 299 0.6× 139 0.3× 184 0.5× 8 1.4k
Qiaoran Xi China 19 1.8k 2.1× 194 0.3× 410 0.9× 408 0.9× 216 0.6× 35 2.3k
Basil A. Horst United States 18 851 1.0× 326 0.6× 381 0.8× 111 0.2× 332 1.0× 45 1.5k
Ahmed El Marjou France 16 833 1.0× 437 0.7× 128 0.3× 353 0.8× 107 0.3× 28 1.4k
Bert Dontje Netherlands 24 1.1k 1.3× 522 0.9× 299 0.6× 106 0.2× 411 1.2× 50 2.1k
Stefan Imreh Sweden 19 864 1.0× 417 0.7× 855 1.8× 106 0.2× 278 0.8× 43 1.8k
Michael J. Klemsz United States 24 1.5k 1.7× 1.3k 2.2× 511 1.1× 112 0.2× 241 0.7× 37 2.8k
Olga Murina United Kingdom 9 1.1k 1.2× 811 1.4× 391 0.8× 152 0.3× 110 0.3× 12 1.6k
Srividya Swaminathan United States 17 1.1k 1.2× 323 0.5× 364 0.8× 149 0.3× 361 1.0× 42 1.6k
Jennifer E. Adair United States 26 1.3k 1.5× 314 0.5× 568 1.2× 86 0.2× 683 2.0× 64 1.9k

Countries citing papers authored by Anna Morena D’Alise

Since Specialization
Citations

This map shows the geographic impact of Anna Morena D’Alise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Morena D’Alise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Morena D’Alise more than expected).

Fields of papers citing papers by Anna Morena D’Alise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Morena D’Alise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Morena D’Alise. The network helps show where Anna Morena D’Alise may publish in the future.

Co-authorship network of co-authors of Anna Morena D’Alise

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Morena D’Alise. A scholar is included among the top collaborators of Anna Morena D’Alise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Morena D’Alise. Anna Morena D’Alise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Micarelli, Elisa, Lauri Moilanen, Matti Annala, et al.. (2025). NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome. Molecular Cancer Therapeutics. OF1–OF12.
2.
Nocchi, Linda, Lidia Avalle, Fulvia Troise, et al.. (2024). Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine. Cancer Immunology Research. 12(4). 440–452. 4 indexed citations
3.
D’Alise, Anna Morena, Guido Leoni, Gabriella Cotugno, et al.. (2024). Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical Cancer Research. 30(11). 2412–2423. 23 indexed citations
4.
Paolis, Elisa De, Camilla Nero, Elisa Micarelli, et al.. (2024). Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer. npj Precision Oncology. 8(1). 283–283. 1 indexed citations
5.
Troise, Fulvia, Guido Leoni, Emanuele Sasso, et al.. (2024). Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors. SHILAP Revista de lepidopterología. 32(1). 200760–200760. 1 indexed citations
6.
Bartolomeo, Rosa, Fulvia Troise, Giulia Sdruscia, et al.. (2024). Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines. 12(3). 325–325.
7.
Seclì, Laura, Linda Nocchi, Gabriella Cotugno, et al.. (2023). Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity. Journal for ImmunoTherapy of Cancer. 11(4). e006718–e006718. 5 indexed citations
8.
Seclì, Laura, Guido Leoni, Valentino Ruzza, et al.. (2023). Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer. International Journal of Molecular Sciences. 24(23). 16591–16591. 21 indexed citations
9.
Sasso, Emanuele, Gabriella Cotugno, Anna Morena D’Alise, et al.. (2020). Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis. Scientific Reports. 10(1). 4307–4307. 22 indexed citations
10.
Cotugno, Gabriella, Linda Nocchi, Francesca Langone, et al.. (2020). Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment. Molecular Therapy — Oncolytics. 19. 253–264. 27 indexed citations
11.
Passariello, Margherita, et al.. (2019). Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling. Scientific Reports. 9(1). 13125–13125. 42 indexed citations
12.
D’Alise, Anna Morena, Guido Leoni, Gabriella Cotugno, et al.. (2019). Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade. Nature Communications. 10(1). 2688–2688. 76 indexed citations
13.
Capone, Stefania, Mariarosaria Naddeo, Anna Morena D’Alise, et al.. (2014). Fusion of HCV Nonstructural Antigen to MHC Class II–associated Invariant Chain Enhances T-cell Responses Induced by Vectored Vaccines in Nonhuman Primates. Molecular Therapy. 22(5). 1039–1047. 29 indexed citations
14.
Capone, Stefania, Anna Morena D’Alise, Virginia Ammendola, et al.. (2013). Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials. Expert Review of Vaccines. 12(4). 379–393. 63 indexed citations
15.
Fassett, Marlys S., Wenyu Jiang, Anna Morena D’Alise, Diane Mathis, & Christophe Benoıst. (2012). Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proceedings of the National Academy of Sciences. 109(10). 3891–3896. 97 indexed citations
16.
Amabile, Giovanni, Robert S. Welner, César Nombela‐Arrieta, et al.. (2012). In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood. 121(8). 1255–1264. 160 indexed citations
17.
D’Alise, Anna Morena, Ayla Ergün, Jonathan A. Hill, Diane Mathis, & Christophe Benoıst. (2011). A cluster of coregulated genes determines TGF-β–induced regulatory T-cell (Treg) dysfunction in NOD mice. Proceedings of the National Academy of Sciences. 108(21). 8737–8742. 34 indexed citations
18.
D’Alise, Anna Morena, Giovanni Amabile, Mariangela Iovino, et al.. (2008). Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Molecular Cancer Therapeutics. 7(5). 1140–1149. 115 indexed citations
19.
D’Alise, Anna Morena, Vincent C. Auyeung, Markus Feuerer, et al.. (2008). The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proceedings of the National Academy of Sciences. 105(50). 19857–19862. 164 indexed citations
20.
Amabile, Giovanni, Anna Morena D’Alise, Mariangela Iovino, et al.. (2008). The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts. Cell Death and Differentiation. 16(2). 321–330. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026